Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Current Medicinal Chemistry
|
September 17, 2011
Designed multiple ligands for cancer therapy
N M O'Boyle, M J Meegan
Current Medicinal Chemistry
|
February 7, 2003
Advances in the science of estrogen receptor modulation
M J Meegan, D G Lloyd
Current Medicinal Chemistry
|
August 5, 2008
Recent developments in the design of anti-depressive therapies: targeting the serotonin transporter
S G Butler, M J Meegan
Current Cancer Drug Targets
|
May 16, 2009
Targeting tumors using estrogen receptor ligand conjugates
N O Keely, M J Meegan
Journal of Microencapsulation
|
July 1, 1989
Preparation and characterization of lactic/glycolic acid polymers and copolymers
P B Deasy, M P Finan, M J Meegan
Drug and Chemical Toxicology
|
January 1, 1990
An evaluation of the acute in vivo toxicity of benzylidenechroman-4-ones, 1-thiobenzylidenechroman-4-ones and benzylidenetetralones
T M Al-Nakib, N J Miller, S Rashid, et al.
Anti-Cancer Drug Design
|
January 5, 2002
Ethyl side-chain modifications in novel flexible antiestrogens--design, synthesis and biological efficacy in assay against the MCF-7 breast tumor cell line
M J Meegan, R B Hughes, D G Lloyd, et al.
Journal of Medicinal Chemistry
|
April 12, 2001
Flexible estrogen receptor modulators: design, synthesis, and antagonistic effects in human MCF-7 breast cancer cells
M J Meegan, R B Hughes, D G Lloyd, et al.
European Journal of Medicinal Chemistry
|
December 17, 2013
Synthesis and antiproliferative action of a novel series of maprotiline analogues
Y M McNamara, S A Bright, A J Byrne, et al.
Oncology Reports
|
March 22, 2019
Selected nitrostyrene compounds demonstrate potent activity in chronic lymphocytic leukaemia cells, including those with poor prognostic markers
S A Bright, A J Byrne, E Vandenberghe, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Current Medicinal Chemistry
|
September 17, 2011
Designed multiple ligands for cancer therapy
N M O'Boyle, M J Meegan
Current Medicinal Chemistry
|
February 7, 2003
Advances in the science of estrogen receptor modulation
M J Meegan, D G Lloyd
Current Medicinal Chemistry
|
August 5, 2008
Recent developments in the design of anti-depressive therapies: targeting the serotonin transporter
S G Butler, M J Meegan
Current Cancer Drug Targets
|
May 16, 2009
Targeting tumors using estrogen receptor ligand conjugates
N O Keely, M J Meegan
Journal of Microencapsulation
|
July 1, 1989
Preparation and characterization of lactic/glycolic acid polymers and copolymers
P B Deasy, M P Finan, M J Meegan
Drug and Chemical Toxicology
|
January 1, 1990
An evaluation of the acute in vivo toxicity of benzylidenechroman-4-ones, 1-thiobenzylidenechroman-4-ones and benzylidenetetralones
T M Al-Nakib, N J Miller, S Rashid, et al.
Anti-Cancer Drug Design
|
January 5, 2002
Ethyl side-chain modifications in novel flexible antiestrogens--design, synthesis and biological efficacy in assay against the MCF-7 breast tumor cell line
M J Meegan, R B Hughes, D G Lloyd, et al.
Journal of Medicinal Chemistry
|
April 12, 2001
Flexible estrogen receptor modulators: design, synthesis, and antagonistic effects in human MCF-7 breast cancer cells
M J Meegan, R B Hughes, D G Lloyd, et al.
European Journal of Medicinal Chemistry
|
December 17, 2013
Synthesis and antiproliferative action of a novel series of maprotiline analogues
Y M McNamara, S A Bright, A J Byrne, et al.
Oncology Reports
|
March 22, 2019
Selected nitrostyrene compounds demonstrate potent activity in chronic lymphocytic leukaemia cells, including those with poor prognostic markers
S A Bright, A J Byrne, E Vandenberghe, et al.
Page
of 2